Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,701.00
Ask: 1,701.50
Change: 32.00 (1.91%)
Spread: 0.50 (0.029%)
Open: 1,685.50
High: 1,718.50
Low: 1,673.00
Prev. Close: 1,673.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Asian data lifts stocks early on

Mon, 02nd Jul 2012 08:30

- Chinese, Japanese data comes in better than expected- RBS falls on Libor issues- Barclays Chairman resignsLondon's blue chips edged higher on Monday morning after manufacturing data in China and Japan boosted sentiment.China's purchasing managers' index (PMI) fell from 50.4 to 50.2 last month, according to the National Bureau of Statistics and China Federation of Logistics and Purchasing, beating forecasts of around 49.9.Meanwhile, Japan's Tankan manufacturers' sentiment survey improved from minus four to minus one in the second quarter, compared to expectations of an unchanged ready.Investors will be looking ahead to policy decisions in both the UK and Europe around Thursday lunchtime. The Monetary Policy Committee (MPC) will be revealing its policy decision with the majority of economists expecting the Bank of England (BoE) to ramp up its asset purchase programme while keeping rates where they are.The European Central Bank (ECB) is anticipated to slash its main refinancing rate to a record-low 0.75%, compared with the current 1% level. 48 of the 71 economists surveyed by Reuters expect a reduction. FTSE 100: Banks continue to be dampened by Libor scandalRoyal Bank of Scotland (RBS) was a heavy faller after Oriel Securities downgraded its rating on the stock to 'hold'. It was revealed at the weekend that the bank had sacked four of its traders last year over the alleged manipulation of interbank lending rates (London Interbank Offered Rate, or LIBOR). Some market reports said that some 10 traders were dismissed, citing unidentified sources.The news comes after last week's revelation that banking peer Barclays had been fined £290m after it was found attempting to control submissions for LIBOR to benefit its interest rate derivatives. The issue prompted the lender's Chairman Marcus Agius to resign this morning. He said he is "truly sorry" that the bank's customers, clients, employees and shareholders have been let down. Barclay swung between gains and losses early on following last week's sell-off.Insurance group Aviva rose after announcing that Chairman Lord Sharman retired as Chairman on June 30th. John McFarlane has taken over.Pharmaceuticals giant AstraZeneca edged higher after saying that Bristol-Myers Squibb's acquisition of Amylin Pharmaceuticals will strengthen the leadership position of its diabetes alliance with Bristol-Myers in a "growing area of high unmet medical need". Astra will make a payment of $3.4bn in cash to Amylin once it becomes a wholly-owned subsidiary of Bristol-Myers.Sector peer GlaxoSmithKline also advanced after revealing positive results from four pivotal phase III studies for its once-daily COPD treatment. The company said that the results of the studies support its intention to commence global regulatory submissions for the treatment from the end of 2012.Serco, the international services company, rose after it signed an agreement to dispose of most of its operations in Germany in a transaction with the local management team.Media giant WPP was in demand after announcing another acquisition; it has agreed to acquire the South Korean media planning and buying agency, Alchemedia, which will be merged into its GroupM Korea subsidiary.FTSE 250: Catlin falls after broker downgradeInsurance group Catlin fell after Jefferies downgraded the stock to 'hold' as part of its review into the European insurance industry: "With Catlin now close to our price target, we downgrade to 'hold' also noting higher end US windstorm exposure and a broadly untouched reinsurance deductible."Oil and gas group SOCO International jumped after entering into a 'conditional' agreement with Lizeroux Oil & Gas to acquire the 20% minority interest in SOCO Vietnam that the group does not already own. FTSE 100 - RisersStandard Chartered (STAN) 1,418.50p +2.46%Barclays (BARC) 166.00p +1.93%WPP (WPP) 786.00p +1.68%Aviva (AV.) 276.80p +1.54%Burberry Group (BRBY) 1,345.00p +1.51%Prudential (PRU) 748.50p +1.42%Lloyds Banking Group (LLOY) 31.50p +1.27%BP (BP.) 427.20p +1.24%G4S (GFS) 282.40p +1.18%Tullow Oil (TLW) 1,487.00p +1.16%FTSE 100 - FallersXstrata (XTA) 780.20p -2.30%Shire Plc (SHP) 1,796.00p -1.97%Glencore International (GLEN) 290.45p -1.73%Royal Bank of Scotland Group (RBS) 211.70p -1.67%Tesco (TSCO) 306.45p -1.16%Vodafone Group (VOD) 177.45p -1.00%Evraz (EVR) 258.30p -0.92%British Sky Broadcasting Group (BSY) 690.50p -0.86%Smith & Nephew (SN.) 632.50p -0.78%International Consolidated Airlines Group SA (CDI) (IAG) 158.30p -0.75%FTSE 250 - RisersSoco International (SIA) 302.80p +4.63%Imagination Technologies Group (IMG) 487.60p +4.50%Aquarius Platinum Ltd. (AQP) 47.40p +3.81%Essar Energy (ESSR) 125.90p +3.20%Invensys (ISYS) 229.00p +2.83%BH Global Ltd. USD Shares (BHGU) 11.45 +2.69%Fenner (FENR) 370.70p +2.60%Shanks Group (SKS) 78.30p +2.55%FirstGroup (FGP) 229.40p +2.27%TR Property Inv Trust (TRY) 151.30p +2.23%FTSE 250 - FallersSpirit Pub Company (SPRT) 49.50p -2.46%Catlin Group Ltd. (CGL) 417.80p -1.81%Victrex (VCT) 1,249.00p -1.73%Cranswick (CWK) 801.00p -1.72%Halfords Group (HFD) 225.50p -1.61%New World Resources A Shares (NWR) 318.60p -1.51%Barr (A.G.) (BAG) 393.60p -1.40%Ruspetro (RPO) 133.40p -1.26%easyJet (EZJ) 525.50p -1.13%Renishaw (RSW) 1,386.00p -1.00%BC
More News
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.